Clinical Trial Update: The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating clevidipine for hypertension in patients requiring intracranial pressure monitoring has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• clevidipine (clevidipine)

Snippet

Sponsor: Mario Ammirati | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN